Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Mangoceuticals (MGRX) Cost of Revenue (2023 - 2025)

Mangoceuticals' Cost of Revenue history spans 3 years, with the latest figure at $8511.0 for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 60.1% to $8511.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $54422.0, a 41.67% decrease, with the full-year FY2025 number at $54422.0, down 41.67% from a year prior.
  • Cost of Revenue hit $8511.0 in Q4 2025 for Mangoceuticals, up from $2359.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for MGRX hit a ceiling of $53362.0 in Q4 2023 and a floor of $2359.0 in Q3 2025.
  • Historically, Cost of Revenue has averaged $25218.2 across 3 years, with a median of $22629.0 in 2023.
  • The widest YoY moves for Cost of Revenue: up 18.96% in 2025, down 89.03% in 2025.
  • Tracing MGRX's Cost of Revenue over 3 years: stood at $53362.0 in 2023, then crashed by 60.03% to $21331.0 in 2024, then tumbled by 60.1% to $8511.0 in 2025.
  • Business Quant data shows Cost of Revenue for MGRX at $8511.0 in Q4 2025, $2359.0 in Q3 2025, and $18815.0 in Q2 2025.